Efficacy and Safety of Sorafenib as Adjuvant and Latter Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma
Clinical trial NCT03097848 · UNKNOWN
Trial details
- NCT number
- NCT03097848
- Sponsor
- Southwest Hospital, China
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-04
- Primary completion
- 2018-12-30
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.